Florian is a Managing Director at the Novartis Venture Fund (NVF) in Basel, Switzerland. Previously, he worked as a Scientific Manager for the R&D Committee of the Novartis Board of Directors, and before that, he held various scientific and drug discovery roles at the Novartis Institutes for BioMedical Research, including as Laboratory Head in target discovery and in early clinical research as Translational Medicine Expert, Autoimmunity. Florian received his MSc degree in Biochemistry from Free University Berlin and his PhD with great distinction in Biochemistry from Ruhr University Bochum, and he completed his postdoctoral training at the Novartis Institutes for BioMedical Research.
Search here
Categories
Recent Posts
Anaveon presents clinical trial OMNIA-2 at the American Society of Clinical Oncology 2023 Annual Meeting
June 5, 2023Anaveon Presents Trial in Progress Data for OMNIA-1 at the American Society of Clinical Oncology 2023 Annual Meeting
June 3, 2023Anaveon presents ANV600, a novel development compound, at the 2023 American Association for Cancer Research Annual Meeting
April 18, 2023
Popular Tags
Archives
- June 2023 2
- April 2023 1
- March 2023 2
- February 2023 1
- November 2022 2
- October 2022 1
- September 2022 1
- July 2022 3
- April 2022 1
- March 2022 1
- December 2021 1
- November 2021 1
- June 2021 1
- March 2021 1
- November 2020 1
- May 2020 1
- April 2019 1
- February 2019 1